Pharmacovigilance

Automating Literature
Surveillance for Adverse Events

Book a Demo
Phamacovigilance Vertical Triangle
Phamacovigilance Vertical Triangle

DistillerSR for Pharmacovigilance

Logo for DistillerSR

for Pharmacovigilance

Sixty percent of the world’s top pharmaceutical companies trust DistillerSR as their fully-validated literature surveillance platform to process ICSRs and safety signals in an automated, real-time, and audit-ready manner.

Why Companies Choose DistillerSR for Pharmacovigilance

Audit Ready Icon

Audit-Ready

Tracks 100% of your literature review. Integrated audit trail, version control, and data navigation mean your data is traceable.

Artificial Intelligence Icon, DistillerSR

Smart & Fast

Identifies 95% of relevant records on average 60% sooner using AI reprioritization and predictive reporting.

Up-To-Date Icon, DistillerSR

Always Up-To-Date Reviews

Automate adverse event tracking and monitoring from materials published daily to ensure patient safety and compliance.

Configurable Icon, DistillerSR

Configurable

Works the way you do through 100% configurable workflows to support any protocol.

Save Time Icon, DistillerSR

Save Time

Reduces literature review times by 35%-50% by automating every stage of
the process and by reusing already collected data.

.

Integrated Icon, DistillerSR

Integrated

Maintain a single source of truth by synchronizing literature review data seamlessly with your reporting applications and safety databases.

Learn More About DistillerSR

Learn More About DistillerSR

Featured Content

Pharmacovigilance Fact Sheet DistillerSR

Pharmacovigilance Fact Sheet

Learn how PV specialists can use DistillerSR to automate literature surveillance and reporting that’s audit-ready and compliant.

Screenshot of DistillerSR Product Video for Pharmacovigilance

Blog

Q&A Blog Post: How Can Automation Support Literature Surveillance for Pharma and Biotechnology?

AI Reprioritization Blog Post DistillerSR

Blog

Ian Stefanison, CTO for DistillerSR, answers questions on how AI reprioritization reduces screening times by as much as 80%, according to one study.

See DistillerSR in Action

See DistillerSR in Action